184 related articles for article (PubMed ID: 16483388)
41. Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy.
Silva MC; Meira ZM; Gurgel Giannetti J; da Silva MM; Campos AF; Barbosa Mde M; Starling Filho GM; Ferreira Rde A; Zatz M; Rochitte CE
J Am Coll Cardiol; 2007 May; 49(18):1874-9. PubMed ID: 17481447
[TBL] [Abstract][Full Text] [Related]
42. Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years' follow-up.
Duboc D; Meune C; Pierre B; Wahbi K; Eymard B; Toutain A; Berard C; Vaksmann G; Weber S; Bécane HM
Am Heart J; 2007 Sep; 154(3):596-602. PubMed ID: 17719312
[TBL] [Abstract][Full Text] [Related]
43. Outpatient continuous inotrope infusion as an adjunct to heart failure therapy in Duchenne muscular dystrophy.
Cripe LH; Barber BJ; Spicer RL; Wong BL; Weidner N; Benson DW; Markham LW
Neuromuscul Disord; 2006 Nov; 16(11):745-8. PubMed ID: 17005398
[TBL] [Abstract][Full Text] [Related]
44. High incidence of electrocardiogram abnormalities in young patients with duchenne muscular dystrophy.
Takami Y; Takeshima Y; Awano H; Okizuka Y; Yagi M; Matsuo M
Pediatr Neurol; 2008 Dec; 39(6):399-403. PubMed ID: 19027585
[TBL] [Abstract][Full Text] [Related]
45. Letter by Giglio and Mangiola regarding article, "Cardiomyopathy in Duchenne muscular dystrophy carrier and her diseased son: similar pattern revealed by cardiovascular MRI".
Giglio V; Mangiola F
Circulation; 2010 Aug; 122(7):e431; author reply e432. PubMed ID: 20713907
[No Abstract] [Full Text] [Related]
46. Neuropsychiatric disorders in males with duchenne muscular dystrophy: frequency rate of attention-deficit hyperactivity disorder (ADHD), autism spectrum disorder, and obsessive--compulsive disorder.
Hendriksen JG; Vles JS
J Child Neurol; 2008 May; 23(5):477-81. PubMed ID: 18354150
[TBL] [Abstract][Full Text] [Related]
47. Becker's muscular dystrophy and orthotopic heart transplantation: perioperative considerations.
Komanapalli CB; Sera V; Slater MS; Burdette M; Tripathy U; Brady G; Hegnell L; Ravichandran PS; Hershberger RE; Song HK
Heart Surg Forum; 2006; 9(2):E604-6. PubMed ID: 16543161
[TBL] [Abstract][Full Text] [Related]
48. Long-term administration of pirfenidone improves cardiac function in mdx mice.
Van Erp C; Irwin NG; Hoey AJ
Muscle Nerve; 2006 Sep; 34(3):327-34. PubMed ID: 16770778
[TBL] [Abstract][Full Text] [Related]
49. A 15-year-old male with progressive muscular dystrophy of the becker type and severe heart failure.
Arq Bras Cardiol; 2000 Apr; 74(4):360-4. PubMed ID: 10967589
[No Abstract] [Full Text] [Related]
50. Can perindopril delay the onset of heart failure in duchenne muscular dystrophy?
Stöllberger C; Finsterer J
J Am Coll Cardiol; 2005 Nov; 46(9):1781; author reply 1782. PubMed ID: 16256886
[No Abstract] [Full Text] [Related]
51. Pharmacological therapies for muscular dystrophies.
Abdel-Hamid H; Clemens PR
Curr Opin Neurol; 2012 Oct; 25(5):604-8. PubMed ID: 22941265
[TBL] [Abstract][Full Text] [Related]
52. Intermittent inotrope infusion for end stage heart failure in Duchenne muscular dystrophy.
van Baalen A; von Spiczak S; Stephani U; Fischer G
Neuromuscul Disord; 2008 Dec; 18(12):1005-6; author reply 1006. PubMed ID: 18952428
[No Abstract] [Full Text] [Related]
53. Duchenne muscular dystrophy: issues in expanding newborn screening.
Kemper AR; Wake MA
Curr Opin Pediatr; 2007 Dec; 19(6):700-4. PubMed ID: 18025940
[TBL] [Abstract][Full Text] [Related]
54. Cardiology: rips repaired.
Steinhardt RA
Nature; 2005 Aug; 436(7053):925. PubMed ID: 16107827
[No Abstract] [Full Text] [Related]
55. Prevalence and patterns of cardiac involvement in duchenne muscular dystrophy.
Ahuja R; Kalra V; Saxena A; Dua T
Indian Pediatr; 2000 Nov; 37(11):1246-51. PubMed ID: 11086308
[No Abstract] [Full Text] [Related]
56. Duchenne muscular dystrophy: an old anesthesia problem revisited.
Hayes J; Veyckemans F; Bissonnette B
Paediatr Anaesth; 2008 Feb; 18(2):100-6. PubMed ID: 18184239
[TBL] [Abstract][Full Text] [Related]
57. Voiding dysfunction in Duchenne muscular dystrophy.
Robson WL; Leung AK
Arch Dis Child; 2004 Jan; 89(1):92. PubMed ID: 14709529
[No Abstract] [Full Text] [Related]
58. Deflazacort use in Duchenne muscular dystrophy: an 8-year follow-up.
Houde S; Filiatrault M; Fournier A; Dubé J; D'Arcy S; Bérubé D; Brousseau Y; Lapierre G; Vanasse M
Pediatr Neurol; 2008 Mar; 38(3):200-6. PubMed ID: 18279756
[TBL] [Abstract][Full Text] [Related]
59. Cardiac arrest during desflurane anaesthesia in a patient with Duchenne's muscular dystrophy.
Smelt WL
Acta Anaesthesiol Scand; 2005 Feb; 49(2):267-9. PubMed ID: 15715635
[No Abstract] [Full Text] [Related]
60. Influence of disease progression on the neuromuscular blocking effect of mivacurium in children and adolescents with Duchenne muscular dystrophy.
Ihmsen H; Schmidt J; Schwilden H; Schmitt HJ; Muenster T
Anesthesiology; 2009 May; 110(5):1016-9. PubMed ID: 19352159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
